Data Foundry

Drug recalls 2024

Klarity-C — Class II drug recall D-0547-2024

Ongoing recall by Imprimis NJOF, LLC, reported 2024-06-19, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0547-2024
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmImprimis NJOF, LLC, Ledgewood, NJ, United States
Recall initiated2024-05-14
Classified2024-06-07
Reported by FDA2024-06-19
DistributedNationwide (US)
Quantity136,005 units
Reason classessterility
NDC71384-0514-05
Lot numbers23APR005, 23AUG016, 23AUG042, 23DEC021, 23JUL013, 23JUL029, 23JUL030, 23JUN010, 23JUN016, 23JUN047, 23MAY024, 23NOV022, 23NOV036, 23OCT039, 23SEP017, 24FEB021, 24JAN018, 24JAN026, 24JAN040, 24MAR005
Expiration dates2024-05-01, 2024-05-15, 2024-05-30, 2024-06-07, 2024-07-04, 2024-07-11, 2024-07-13, 2024-07-25, 2024-08-01, 2024-08-03, 2024-08-07, 2024-08-24, 2024-08-29, 2024-09-27, 2024-10-04, 2024-10-11, 2024-10-24, 2024-11-02, 2024-11-16, 2024-12-12

Product

Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY Compounded by: Imprimis NJOF, LLC., 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852 NDC: 71384-514-05

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0547-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.